Navigation Links
The Ocean Becomes a Pipeline To A Cure for Cystic Fibrosis
Date:7/9/2008

- Surfing Becomes First Sport To Mitigate the Impact of a Disease

- Surfing Legends Laird Hamilton and Dave Kalama Co-Host Inaugural Gala to Raise Research Funds

HUNTINGTON BEACH, Calif., July 9 /PRNewswire-USNewswire/ -- Amazingly, surfers have unknowingly held a key to prolonging the lifespan and quality of life for people with cystic fibrosis (CF), a fatal genetic disease that causes the body to produce thick, sticky mucus, which clogs the lungs and leads to life-threatening lung infections.

Several years ago, doctors in Australia noticed young surfers with cystic fibrosis had significantly healthier lungs. The doctors determined that inhaling saltwater mist has a powerful effect on rehydrating the lining of the lungs and allowing CF patients to more easily eliminate bacteria-contaminated mucus. This discovery led researchers to develop a hypertonic saline solution, which CF patients around the world now inhale every day. In essence, CF patients now mimic a "surf session" on a daily basis.

More than 70,000 CF patients face a daily battle, enduring hours of daily therapies and treatments to avoid the threat of mucus build-up in the lungs. While average life expectancy has doubled in the past 25 years to age 37 -- due to advances in treatment and care -- funding is still urgently needed to find the miracle drug leading to a cure.

The recent "saltwater" breakthrough treatment has led the Southern California Chapter of the Cystic Fibrosis Foundation to form a "PIPELINE TO A CURE" campaign to raise funds and to bring about global awareness of the unique bond between the sport of surfing and those with cystic fibrosis.

On July 19, 2008, the Cystic Fibrosis Foundation together with honorary co-chairs and surf legends Laird Hamilton and Dave Kalama will host an inaugural gala at the Hyatt Regency Huntington Beach, California, also known as "Surf City."

Title sponsor PacSun and supporting sponsors the Kelly Slater Foundation, BJ's Restaurants, the Tony Hawk Foundation, Wahoo's Fish Taco, and Coast Benefit Consultants hope to generate a major groundswell to increase awareness and support for the Cystic Fibrosis Foundation. LACarGuy Mike Sullivan has donated a Toyota Prius for the opportunity drawing. Many silent and live auction items are "priceless" as the entire surf industry has gotten on board and donated many "epic" items.

Emcee Rick Dickert of Fox 11 Morning News and Good Day LA, auctioneer Shawn Parr of Go Country 105 FM will be joined by special musical guest acoustic SOCIAL DISTORTION at the event.

"This wonderful and direct connection between surfing and cystic fibrosis is unparalleled," commented PIPELINE TO A CURE Co-Chair Jerry Hennessy. "Participating in the sport of surfing is actually good for CF patients, and we believe we can use the power and 'soul' of surfing to raise tremendous awareness and dollars for CF research."

At the PIPELINE TO A CURE event, the Cystic Fibrosis Foundation will be honoring Wing Lam, Ed Lee and Mingo Lee, the owners of Wahoo's Fish Taco, for their many years of support for the CF Foundation and other worthwhile causes.

Surf over to http://www.pipelinetoacure.com/ for more information and to view a YouTube(R) video of one very special surfer, named Emily.

About the Cystic Fibrosis Foundation

The Cystic Fibrosis Foundation is the leading organization devoted to curing and controlling cystic fibrosis. Headquartered in Bethesda, Md., the Foundation funds CF research, has 80 chapter and branch offices throughout the country, and accredits a nationwide network of 115 CF care centers, which provide vital treatments and other CF resources to patients and families. To advance the search for a cure, CFF has invested nearly $300 million in promising scientific research in the biotechnology industry since 1998. As a result, the Foundation has more than 30 potential therapies in its drug discovery and development pipeline. Virtually every approved CF drug available today was made possible because of Cystic Fibrosis Foundation support. For more information visit - http://www.cff.org/.


'/>"/>
SOURCE Cystic Fibrosis Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen-Deprivation Therapy
2. Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and Performance
3. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
4. Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
5. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
6. SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR Annual Meeting
7. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
8. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
9. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
10. Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
11. IDM Pharma Provides Update of Product Pipeline and Announces Plans to Evaluate Strategic Alternatives for the Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017 Research and ... Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through ... their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming Production ... an in-depth assessment of the current trends in the ...
(Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., ... specialty drug prescribing process, today announced it closed $25 million ... a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included participation ... round in 2014, and GV (formerly Google Ventures). ...
(Date:4/20/2017)... NeuroVive Pharmaceutical AB (Nasdaq Stockholm: ... preclinical results demonstrating anti-fibrotic effects with NV556, ... (NASH), in an additional well-validated experimental NASH ... previously shown similar anti-fibrotic effects in the ... present novel data demonstrating anti-fibrotic effects of ...
Breaking Medicine Technology:
(Date:4/21/2017)... ... ... The Patient Advocacy Community of The Beryl Institute presented Eve DeVaro, Director, Patient ... Award in recognition of her extraordinary contributions to the field of patient advocacy ... Institute’s annual Patient Experience Conference on March 20 in Denver, Colorado. ...
(Date:4/21/2017)... Hong Kong (PRWEB) , ... April 21, 2017 , ... ... Printing (U3DP), the first 3D printing facility among higher education institutions in Hong Kong ... 3D printing, in terms of the range and quantity of facilities in Hong Kong. ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... AWARE: A Week of Addiction and Recovery Education, from April 24 to April ... preventing substance use disorders. , The mission of AWARE is to instill ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... announced an exciting new partnership with the highly regarded and well renowned Asian ... highly innovative, myTAP & myTAP PAP Nasal Pillow Mask, and will stabilize and ...
(Date:4/21/2017)... Worcestershire, UK (PRWEB) , ... April 21, 2017 ... ... Award for Enterprise in the category of International Trade, the UK’s most prestigious ... in international trade, which represents 95% of total revenues and has grown by ...
Breaking Medicine News(10 mins):